Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 08/24 09:26:32 pm
96.93 USD   -4.02%
08/22 S&P 500 MOVERS : Mro, regn
08/15 VERTEX PHARMACE : Provides Update on Ongoing Phase 3 Program for VX-..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/18/2016 08/19/2016 08/22/2016 08/23/2016 08/24/2016 Date
99.1(c) 98.01(c) 100.96(c) 100.99(c) 96.93 Last
744 572 891 947 1 346 614 844 279 853 579 Volume
-0.79% -1.10% +3.01% +0.03% -4.02% Change
More quotes
Financials ($)
Sales 2016 1 769 M
EBIT 2016 271 M
Net income 2016 -65,6 M
Finance 2016 347 M
Yield 2016 -
Sales 2017 2 451 M
EBIT 2017 823 M
Net income 2017 468 M
Finance 2017 1 347 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 54,57
EV / Sales2016 13,9x
EV / Sales2017 9,66x
Capitalization 25 023 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
08/22 S&P 500 MOVERS : Mro, regn
08/15 VERTEX PHARMACEUTICALS INCORPORATED : Provides Update on Ongoing Phase 3 Program..
08/11 OPHTHOTECH : Announces Election of Ian F. Smith, Vertex Executive Vice President..
08/04 VERTEX PHARMACEUTICALS : Trek Therapeutics Acquires Two Antiviral Inhibitors Fro..
08/01 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
07/28 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Processes for P..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/27DJVERTEX PHARMACEUTICALS : Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
07/27 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
07/27 VERTEX PHARMACEUTICALS : reports 2Q loss
More news
Sector news : Bio Therapeutic Drugs
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
08/22DJPFIZER : to Acquire Medivation in Deal Worth $14 Billion -- 4th Update
08/22DJPFIZER : to Acquire Medivation in Deal Worth $14 Billion -- 3rd Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/23 Who's Next After Medivation?
08/19 Bayer/CRISPR Therapeutics joint venture Casebia Therapeutics establishes oper..
08/17 Prospects of cystic fibrosis candidate PTI-428 has Proteostasis on a run; sha..
08/17 Vertex Weathers Miss As Bigger Catalysts Loom
08/15 After Hours Gainers / Losers
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 110 $
Spread / Average Target 9,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Simon Bedson SVP & GM-International Commercial Operations
Ian F. Smith CFO, Executive VP & Principal Financial Officer
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-19.74%25 023
AMGEN, INC.7.44%130 514
GILEAD SCIENCES, INC.-19.49%107 513
CELGENE CORPORATION-4.80%88 371
REGENERON PHARMACEUTIC..-22.52%44 288
ACTELION LTD17.62%18 523
More Results